Treatment of multibacillary leprosy following the development of dapsone hypersensitivity syndrome
Background: World Health Organization (WHO) multi-drug therapy (MDT) is the current standard treatment for leprosy. A wide range of frequency of adverse effects caused by MDT has been reported. Dapsone hypersensitivity syndrome (DHS) is a serious adverse effect caused by dapsone. Prompt withdrawal o...
Main Author: | Sudarsono |
---|---|
Format: | Article |
Language: | English |
Published: |
Universitas Indonesia
2019-12-01
|
Series: | JDVI (Journal of General Procedural Dermatology & Venereology Indonesia) |
Subjects: | |
Online Access: | http://www.jgenprodvi.ui.ac.id/index.php/jdvi/article/view/123 |
Similar Items
-
Dapsone hypersensitivity syndrome overlaps reversal reaction in leprosy patient
by: Chesia Christiani Liuwan, et al.
Published: (2019-06-01) -
An unusual case of dapsone syndrome
by: Mary Grace
Published: (2011-01-01) -
Methemoglobinemia and dapsone levels in patients with leprosy
by: Jose Luiz Fernandes Vieira, et al. -
Dapsone syndrome with acute renal failure during leprosy treatment: case report
by: Edson Nogueira Alves-Rodrigues, et al. -
Dapsone hypersensitivity syndrome in an adolescent during treatment during of leprosy Síndrome de hipersensibilidade à dapsona em uma adolescente durante tratamento de hanseníase
by: Fábio Bucaretchi, et al.
Published: (2004-04-01)